Developing engaging, factual and high-quality content can be challenging, particularly in the heavily regulated pharmaceutical industry. As healthcare professionals and patients adapt to the internet of things (IoT) era, their expectations around access to information are continuously evolving. At least 8 out of 10 people turn to search engines as their first source for health information1, so how do we develop medical content that meets your customers’ needs and stands out from the crowd?
Develop a clear content strategy
Whilst marketers spend months each year brand planning, it
can be easy for medical teams to skip the content planning phase. However, developing
a clear strategy to identify the objectives of the content you are looking to
create is key to success. You can start by answering the following questions:
Who is your intended audience?
What topics do you want to share as a thought
leader in your field?
Which platforms are you going to use to share
What story are you trying to tell?
How will you make sure this content stands-out?
Which initiatives are you looking to support
with this content?
What are your key performance indicators?
Seek advice and collaborate
In order to ensure your content is of the highest quality
you need to make sure it resonates with your intended audience. The best way to do this is to engage with
customers to get their feedback on your ideas and throughout the content
development lifecycle. This ensures that the content you are producing not only
meets your objectives but theirs too. You could do this by setting up a
steering committee online using platforms like our very own conversation
Plan for approvals
One potential barrier
to creating engaging content is the approval process, which can be challenging
and lengthy. Streamline the process by engaging reviewers early in your plans
and getting their buy in to your approach. Ensure content is code-compliant and
referenced properly before it goes into the approval system.
Do your research and make sure it’s authentic
It is often perceived that most medical content is produced by marketers. While it is true that we need to learn from our marketing colleagues and make sure that content is easy to understand and digest, we also need to make sure it doesn’t come across as too promotional. Medical content should be well researched and referenced as well as being factual. The real benefit comes from translating these facts into something meaningful for the audience with insights about how it will change their lives, practice or understanding.
Make sure it’s accessible
an engaging piece of content is only half the job. It’s only valuable if
customers can access it. It’s key to make sure you have a dissemination plan to
communicate your asset both internally and externally.
Measure performance and adapt
After your asset has been available for a while, it’s
important to reflect on the performance against your key performance indicators.
Use these insights to adapt your content strategy accordingly and keep creating
medDigital is a specialist medical communications agency for the life sciences industry.
We are a team with expertise in many therapy areas who specialize in digital. We combine insightful science with seamless digital communications to transform patients’ lives.
We have also developed medCrowd, the instant messenger for health and care that protects confidential information to the required standards, which is being used by health and care professionals all over the world.
Client Relationship Manager or Senior Account Manager
Due to our continued international growth, we are looking for someone who wants to progress their career in a dynamic and exciting environment. You will be working with both our internal team and our clients within the life sciences industry, this is an opportunity to take on a varied and interesting role. If you want digital communications to transform patients’ lives, then you will fit in well with our team. Your role will involve:
Working with our clients to build strong relationships and help them get the work done.
Leading regular client meetings with our team to help keep projects on track.
Overseeing project estimates and budgets.
Supporting pitches and new business proposals.
Optimising sales and account management process to constantly improve how we work.
Identifying new opportunities with clients.
Help the medDigital team to exceed client expectations.
What do I need to apply?
3+ years experience leading client projects in medical or healthcare communications, advertising or PR within the life sciences industry.
Excellent organisational skills.
Flexibility whilst working under pressure.
What is desired?
Experience leading digital activities, such as website content, Facebook pages or Twitter accounts with the life science industry.
Familiarity with agile ways of working.
A scientific background is a plus but not essential as our team of Scientific Advisors will be on hand to work with you.
What qualifications or authorisations do I need?
Minimum of 3+ years of relevant experience.
UK work authorisation.
Where will I be based? You will be based at our office on the London South Bank with skyline views, great events and free beer! Flexible working is also available. You will also need to visit our clients’ offices from time to time which may involve international travel.
6% qualifying earnings employer contribution PQM pension
Private healthcare with BUPA
Life Insurance (5x your basic annual salary)
Generous 25-day annual leave allowance
£500/year training allocation
Team reward activities
Laptop and current mobile phone
How can you apply? To apply please send your CV to email@example.com and complete our on-line application form: https://www.meddigital.com/hr/entry/
Social media presents a fantastic opportunity for keeping in touch with your wider audiences. Posting videos can be especially useful for sharing engaging educational content, highlights from conferences or key updates on a therapy area. But with many social media users scrolling through hundreds of posts per session, you have to be savvy to draw someone in and keep them interested.
Remember that viewers on social media may not
understand complex topics and scientific language, so it is important to
explain information in a clear and simple way. Imagine you are telling the
viewer a story. This format helps to keep the viewer engaged while making sure
that the flow of the information is easy to follow.
1. Have a clear beginning, middle and end
When conveying the story, it is important to
have a clear beginning, middle and end. Try to share the ‘why’ before the
‘how’, so that each point clearly and simply leads on to the next. This will
help to keep the viewer engaged and interested throughout the video.
2. Avoid jargon
Viewers on social media may not understand
specialized scientific terms. It is important to keep messages simple and to
avoid jargon. One way to reduce specialized vocabulary is to consider your
language through the eyes of someone you know – perhaps someone without a
professional science background at all.
3. Be light on the detail
Try to resist explaining too much too soon. If
detail is not directly relevant to your key points, it is best to avoid
including this completely. If the detail is essential, make sure that you share
this only once the viewer understands the basic concept.
4. Use analogies and examples
Using examples and analogies can help a viewer
to understand complex topics, as it gives them a frame of reference. Even if an
analogy is not 100% accurate, it may help to get your point across without confusing
5. Talk to the viewer as an individual
Using the first person as much as possible is
important when trying to educate. It helps to keep the viewer engaged, which is
key when discussing a complex topic.
6. Make the content relevant
Why is the topic important to the viewer? As
interesting as the science may be, public audiences are not likely to engage
unless it has relevance to them. Try explaining the end goal of the research or
how it could directly impact patients, even if this is far in the future.
Interested in creating a compelling scientific video? At medDigital we love turning complex science into powerful and digestible content. We offer a range of content services that can support you in engaging your audiences.
The Royal College of Physicians and Surgeons of
medDigital fully align with the mission
of FPM “to advance the science and practice of pharmaceutical medicine by
working to develop and maintain competence, ethics and integrity and the
highest professional standards in the specialty for the benefit of the public”.
FPM members work in diverse areas in order to achieve this, from clinical
trials, pharmaceutical marketing and regulatory affairs. They aim to improve
health of the public through their activities, including discovery,
development, evaluation, licensing and monitoring of medicines.
In our article, we wanted to
highlight the importance of digital innovations in healthcare and offer an overview
of the support available in the UK environment. We believe that all modern
healthcare systems, including the NHS, should adapt to the technological
developments in order to ensure patients receive the care they need, quickly
and efficiently. For instance, in 2018 and early 2019 we have seen numerous
medical applications (Apps), wearables, virtual reality systems emerging in the
healthcare start-up environment. These new technologies are enabling real-time
diagnosis, tele-monitoring of symptoms and health progress tracking. In our
article we listed organisations and initiatives, such as DigitalHealth.London
Accelerator, Health Foundry, Digital Catapult and MedCity who are doing the essential work
of offering useful services and shaping the right ecosystem for digital
innovations to flourish.
Transforming patients’ lives is
at the heart of all the work we do at medDigital. We believe that insightful
science combined with digital means can upgrade health and we are advocates of
the digital movement in healthcare and its supporters.
What are the most challenging aspects of pharma today? What should be the main focus for the industry going forwards?
These were the key questions behind the very first edition of NEXT Pharma Summit, held in Dubrovnik, Croatia, in May 2019.
The international experts who stepped on the stage expressed some key reflections: the challenge of gathering and sharing engaging information online, developing digital multichannel excellence, bridging the gap between pharma, healthcare professionals (HCPs) and individual patients, and understanding why pharma appears to be trailing behind all other industries in the race for a digital presence.
In a brilliant talk, Tim Cave (GSK) discussed the need for virtual communication channels in this day and age. He highlighted that in the coming years, 70% of HCPs will be digital natives. In his opinion, the pharmaceutical industry cannot quite capture a key need of this generation: going digital.
Doctors repeatedly express the desire for fast, accessible, digital information, and have been asking for virtual conferences, digital insights and virtual communication channels. However, there are many historical and regulatory reasons hindering the race to digitise pharma. Despite that, the industry must tackle this challenge and ensure it can be up to speed with the ever-evolving and constant technological development. Most consumer industries, such as transportation, communication and fintech have made a gigantic shift into digital – why can’t pharma?
Another great contribution was made by Laura Greco during both a talk and a group panel. A 40-year-old lawyer-turned-patient-advocate, with a stage 4 ALK+ lung cancer diagnosis, made a strong case for the patients’ right to be informed and involved in decisions about their own treatment.
She highlighted the value of social media during her patient journey. This hits home for many stakeholders in the pharmaceutical industry – the value of sharing accurate, engaging and relevant content online will enable both HCPs and patients to access information and create closer ties with the community.
Laura Greco also discussed the need for transparency at the R&D stage. She reported often finding herself unaware of her personal patient history data being used in scientific publications, or not knowing the outcome of clinical trials she had personally been a part of. This is another opportunity for the industry to bridge a gap – patients and pharma should be able to work together to find answers and advance research.
Our very own founder Felix Jackson also gave a talk about Dynamic Digital Content & Real-Time Expert Engagement. He presented the growing need to turn data into actionable insights and improve current communication channels. A solution can be found if the pharmaceutical industry expands into new digital options, such as online content creation and Digital Advisory Boards.
Providing a digital space for HCPs to offer expert insights, which also doubles as a place for patients to efficiently liaise with pharma, can overcome some of the key barriers that we know are holding stakeholders back from a digital revolution. This could be a lack of human resource or talent, compliance barriers, or lack of financial support.
Our technology, medCrowd, offers a compliant and accessible option to help pharma transition into a digital route, in order to lead the conversation and easily discover actionable insights with Digital Advisory Boards.
had a wonderful time at NEXT Pharma 2019, and we’re already getting ready for
the NEXT Pharma Summit 2020!
stunning backdrop of Dubrovnik will be expecting us once again on the 6th
and 7th of May 2020, for a weekend packed with influential speakers,
new ideas and incredible insights.
Did you attend NEXT Pharma 2018? What did you think of it? Get in touch and let us know!
The World Health Organisation (WHO) released their first guidance on digital technologies in healthcare last month. Given the vast scale of the digital health industry, the recommendations in this guideline cover just a small subset of digital interventions, with the intention to expand in future versions. Reviewing the evidence and assessing the risks, the WHO hopes that this guidance will help policy-makers to make informed investments, supporting all areas of the industry from providers to patients.
Digital technologies continue to evolve the world around us, and healthcare has been no exception. From artificial reality (AR) aiding diagnosis to virtual reality (VR) for healthcare professional training, we continue to see innovators developing new technologies to shape the industry. But how many of these innovations actually have a strong evidence base? How do we know if they truly have a tangible benefit? These, amongst others, were the questions that the new WHO guidance sought to address.
The recommendations covered a wide range of digital
Birth notification via mobile devices
Death notification via mobile devices
Stock notification and commodity management via
Targeted client communication via mobile devices
Health worker decision support via mobile
Digital tracking of clients’ health status and
services combined with decision support and targeted client communication
Digital provision of training and educational
content to health workers via mobile devices/mobile learning
For some recommendations, the WHO suggested that digital
solutions should act as a complement to traditional methods, rather than as a
replacement. For others, the ability for the health system to support
implementation in an integrated manner was highlighted as key. Indeed, it is
important to recognise that digital health interventions cannot substitute key
components needed by a health system, such as workforce, leadership and
The WHO recognised that while recommendations were based on distinct digital interventions, the whole picture is more convoluted and interlinked. The executive summary provides an interesting infographic explaining some of these links between the recommendations. The publication of the first WHO guidance on digital technologies is a key step in recognising the importance of digital health advancements around us today. It is also important in ensuring that health systems can reliably choose technologies that are effective and work for the people who need them.By Alex Teckkam